Adial Pharmaceuticals
ADIL
$1.44
Share price
-4.02%
Change (1 day)
379.90%
Change (1 year)
Categories
EPS for Adial Pharmaceuticals (ADIL)
EPS in 2023 (TTM): $15.50
According to Adial Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $15.50. In 2022 the company made an earnings per share (EPS) of -$108.00 a decrease over its 2021 EPS that were of -$26.25.
EPS history for Adial Pharmaceuticals from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $15.50 | -114.35% |
| 2022 | -$108.00 | 311.43% |
| 2021 | -$26.25 | 22.09% |
| 2020 | -$21.50 | -4.44% |
| 2019 | -$22.50 | -50.18% |
| 2018 | -$45.16 | 721.75% |
| 2017 | -$5.50 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -100.39% | Bahamas |
 NRC Health
NRC | $1.19 | -92.32% | 🇺🇸 USA |